相关实验视频
Updated: Jul 7, 2026

18:25
Orthotopic Liver Transplantation in Rats
Published on: July 1, 2012
29.9K
对于患有慢性肝病的儿童来说,肝移植的时间和症状
Risheka Lakshmi Suthantirakumar1, Girish L Gupte2
1Specialised Foundation Programme in Paediatrics, Imperial College London NHS Hospital Trust, London W2 1NY, UK.
Children (Basel, Switzerland)
|May 1, 2025
概括
肝移植 (LT) 为患有慢性肝病 (CLD) 的儿童提供了更好的生存期. 及时识别脱补偿和仔细选择患者对于成功的儿科肝移植至关重要.
科学领域:
- 儿科肝病学 儿科肝病学
- 移植手术 移植手术
- 胃肠病学 胃肠病学
背景情况:
- 儿童慢性肝病 (CLD) 存在重大管理挑战.
- 肝移植 (LT) 是改善儿科CLD的长期存活率的重要干预措施.
- 多种不同的病因导致儿科CLD,包括胆固醇性疾病,代谢疾病和恶性瘤.
研究的目的:
- 审查儿科患者肝移植的不断变化的指示和时间.
- 突出 LT 技术和免疫抑制疗法的进步.
- 强调早期脱补偿识别和患者选择的重要性.
主要方法:
- 关于儿科肝移植的文献综述.
- 对L.T.目前的适应性和适应性情况的分析.
- 讨论各种移植方式及其适合儿科接受者.
主要成果:
- 对于患有肝衰竭的儿科CLD,包括胆道缩,代谢性疾病和肝细胞癌,LT是适用的.
- 新出现的迹象包括线粒体肝病变和慢性肝衰竭的急性肝病.
- 在LT技术和免疫抑制方面的进步改善了患者和移植的存活率.
结论:
- 肝移植是管理儿科CLD的基石,提供了更好的生存率.
- 最佳的结果取决于仔细的患者选择,多学科的合作,和精细的移植协议.
- 解决儿科肝病不断变化的局面需要在LT方面不断取得进展.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

